These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9437719)

  • 21. Responses of pancreatic b cells to alloxan and streptozotocin in the guinea pig.
    Gorray KC; Baskin D; Brodsky J; Fujimoto WY
    Pancreas; 1986; 1(2):130-8. PubMed ID: 2953022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-diabetic and streptozotocin-diabetic rats.
    Jaffa AA; Pratt J; Ashford A; Bailey GS
    Agents Actions; 1984 Dec; 15(5-6):478-81. PubMed ID: 6241788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
    Ader M; Richey JM; Bergman RN
    Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on hypoglycemic effect of extract of Balaophora polyandra in mice].
    Tian JY; Ji TF; Su YL; Cong WN; Liu ZL; Ye F
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(12):1194-8. PubMed ID: 17802886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
    Nonaka N; Shioda S; Niehoff ML; Banks WA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.
    Banks WA; Kastin AJ
    Peptides; 1998; 19(5):883-9. PubMed ID: 9663454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity-inducing lesions of the central nervous system alter leptin uptake by the blood-brain barrier.
    Banks WA; King BM; Rossiter KN; Olson RD; Olson GA; Kastin AJ
    Life Sci; 2001 Oct; 69(23):2765-73. PubMed ID: 11720081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
    Lacković Z; Salković M
    Life Sci; 1990; 46(1):49-54. PubMed ID: 1688991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lipopolysaccharide on leptin transport across the blood-brain barrier.
    Nonaka N; Hileman SM; Shioda S; Vo TQ; Banks WA
    Brain Res; 2004 Jul; 1016(1):58-65. PubMed ID: 15234252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
    Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
    Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of LPS on the permeability of the blood-brain barrier to insulin.
    Xaio H; Banks WA; Niehoff ML; Morley JE
    Brain Res; 2001 Mar; 896(1-2):36-42. PubMed ID: 11277970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia.
    Chi OZ; Kiss GK; Mellender SJ; Liu X; Weiss HR
    Neurosci Lett; 2017 Jul; 654():17-22. PubMed ID: 28625574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of diabetes on transport through the blood-retinal and blood-brain barriers in rats.
    Taarnhöj J; Alm A
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):291-3. PubMed ID: 1831178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis.
    Das J; Vasan V; Sil PC
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):296-308. PubMed ID: 22138235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions.
    da Silva AA; Hall JE; do Carmo JM
    PLoS One; 2017; 12(11):e0184805. PubMed ID: 29190687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development.
    Diamond MP; Moley KH; Pellicer A; Vaughn WK; DeCherney AH
    J Reprod Fertil; 1989 May; 86(1):1-10. PubMed ID: 2526873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
    Awad AS
    Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
    Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
    Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
    Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
    J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.
    Kastin AJ; Akerstrom V; Pan W
    J Mol Neurosci; 2002; 18(1-2):7-14. PubMed ID: 11931352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.